地方政府层面的医药研发激励政策扩散研究

Research on policy diffusion in pharmaceutical research and development incentive at the local government level

本文收集整理了2009—2019年我国中央政府颁布的医药研发激励政策和在地方政府扩散的相应政策,运用政策扩散分析方法和网络分析方法,从扩散力度、速度、广度等指标出发,对我国医药研发激励政策在地方政府的扩散情况进行分析,探究我国地方政府落实和推动中央医药研发激励政策的整体情况。研究结果发现,2016年后我国医药研发激励政策在地方政府层面均有明显提高;中医药发展、审评审批制度改革和研发激励内容比重较大的政策扩散力度、广度排在全部政策前列;不同省份扩散中央政策的力度和响应中央政策的速度存在较大差异。本研究结果将为十四五期间地方行政系统和医药研发激励政策体系的优化,以及政府效能评价工作提供实证依据。

This paper examined the state-to-local policy diffusion in China s pharmaceutical research and development incentive during the period from 2009 to 2019 using the collected central and local government incentive policies.This research applied the methods of policy diffusion analysis and network analysis to explore how central incentive policies in pharmaceutical R&D diffused and how the local governments implemented those policies in terms of diffusion strength,speed and width.The results showed that the state-to-local policy diffusion in China s pharmaceutical R&D has significantly improved after 2016.The policies related to the development of Traditional Chinese Medicine,the reform of the review and approval system and R&D incentives were widely spread among all policies.The strength and speed of policy diffusion varied considerably among different provinces.This study provides empirical evidence for optimizing China s pharmaceutical R&D system and local government administration in the 14 th Five-Year Plan,as well as building capacity for the government performance appraisal.